Operate A Chemical Surety Program And Studies Supporting The Medical Chemical Defense Research Program

2010 ◽  
Author(s):  
Michael C. Babin
Science ◽  
1985 ◽  
Vol 229 (4708) ◽  
pp. 36-36
Author(s):  
David Dickson

1990 ◽  
Vol 9 (1) ◽  
pp. 85-92
Author(s):  
Thomas R. Dashiell

The biological defense research program maintained by the Department of Defense as a deterrent to the potential use of biological warfare against United States forces or national interests has been subjected to intense criticism. Concerns center on developments in the protective programs and the potential for new offensive developments through the application of biotechnology. The arms control activities intended to preclude any offensive developments are reviewed which point out the relative ineffectiveness of these control mechanisms. The nature, scope and direction of the biological defense research program and the openness of the program are noted. The proliferation of biological warfare capabilities adds to the urgency of an adequate defense program. The political nature of the problem and its relationship to control of biological warfare is examined and the interplay between the technical and the political roles leads to a potential solution. Key attributes of a control program should be enhanced efforts to develop the political framework to achieve effective control mechanisms while maintaining a complementary biological defense research program as the only effective deterrent at this time.


Science ◽  
1985 ◽  
Vol 229 (4708) ◽  
pp. 36-36
Author(s):  
D. DICKSON

1992 ◽  
Vol 666 (1 The Microbiol) ◽  
pp. 131-145 ◽  
Author(s):  
JOHN QUIGLEY

1990 ◽  
Vol 9 (1) ◽  
pp. 77-84 ◽  
Author(s):  
Charles F. Dasey

The U.S. Army conducts the Biological Defense Research Program to provide medical protection for U.S. military personnel against the threat of biological weapons. The unclassified medical research program is consistent with the Biological Weapons Convention, which prohibits the production and stockpiling of biological and toxin weapons, and encourages the international exchange of scientific and medical information on the prevention and treatment of infectious diseases. The program is the source of secondary benefits to civilian public health in the form of vaccine and drug development, diagnostic capability, and contributions to the world body of knowledge on infectious diseases. As the executive agent for the program, the Army submits descriptions of the work conducted under the program to Congress as part of its budget request, and provides numerous other responses to Congressional scrutiny of the program. Internal monitoring of the program is conducted from the perspectives of safety, compliance with regulatory agencies, quality assurance, and close administrative and technical oversight of contracts.


1990 ◽  
Vol 9 (1) ◽  
pp. 117-121
Author(s):  
Robert J. Rutman ◽  
Harry J. Disch

In so far as any new technology or information in biology or biomedicine is also potentially relevant to biological warfare (BW), and therefore to the Biological Defense Research Program (BDRP), BDRP is equivalent to a biore-search program, making it, ipso facto, unnecessary. The papers by Dashiell and Dasey reviewed herein certainly present this equivalence and provide very little, if any, justification of BDRP as having a unique, distinctive military role requiring budgetary dispensations. In fact, the only specific military role mentioned for BDRP, that of protecting personnel, would utilize military means developed for chemical warfare.


2009 ◽  
Vol 60 (2) ◽  
pp. 173-177 ◽  
Author(s):  
Ante Vučemilović ◽  
Mirko Hadžija ◽  
Ivan Jukić

Skin Decontamination with Mineral Cationic Carrier Against Sarin DeterminedIn VivoOur Institute's nuclear, biological, and chemical defense research team continuously investigates and develops preparations for skin decontamination against nerve agents. In thisin vivostudy, we evaluated skin decontamination efficacy against sarin by a synthetic preparation called Mineral Cationic Carrier (MCC®) with known ion exchange, absorption efficacy and bioactive potential. Mice were treated with increasing doses of sarin applied on their skin, and MCC® was administered immediately after contamination. The results showed that decontamination with MCC® could achieve therapeutic efficacy corresponding to 3 x LD50of percutaneous sarin and call for further research.


Sign in / Sign up

Export Citation Format

Share Document